Page 250 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition

CHAPTER 13 Radiation Oncology 229

197. Baker-Gabb M, Hunt GB, France MP: Soft tissue sarcomas and 218. Dernell WS, Van Vechten BJ, Straw RC, et al.: Outcome following
mast cell tumours in dogs; clinical behaviour and response to sur- treatment of vertebral tumors in 20 dogs (1986-1995), J Am An
gery, Aust Vet J 81:732–738, 2003. Hosp Assoc 36:245–251, 2000.
VetBooks.ir 198. McSporran KD: Histologic grade predicts recurrence for margin- 219. McEntee MC, Page RL, Novotney CA, et al.: Palliative radiother-
apy for canine appendicular osteosarcoma, Vet Radiol Ultrasound
ally excised canine subcutaneous soft tissue sarcomas, Vet Pathol
34:367–370, 1993.
46:928–933, 2009.
199. Bray JP, Polton GA, McSporran KD, et al.: Canine soft tissue sar- 220. Wolfe TD, Pillai SP, Hildreth III BE, et al.: Effect of zoledronic
coma managed in first opinion practice: outcome in 350 cases, Vet acid and amputation on bone invasion and lung metastasis of
Surg 43:774–782, 2014. canine osteosarcoma in nude mice, Clin Exp Metastasis 28:377–
200. Monteiro B, Boston S, Monteith G: Factors influencing complete 389, 2011.
tumor excision of mast cell tumors and soft tissue sarcomas: a ret- 221. Arrington SA, Damron TA, Mann KA, et al.: Concurrent admin-
rospective study in 100 dogs, Can Vet J 52:1209–1214, 2011. istration of zoledronic acid and irradiation leads to improved bone
201. Cronin K, Page RL, Spodnick G, et al.: Radiation therapy and sur- density, biomechanical strength, and microarchitecture in a mouse
gery for fibrosarcoma in 33 cats, Vet Radiol Ultrasound 39:51–56, model of tumor-induced osteolysis, J Surg Oncol 97:284–290,
1998. 2008.
202. Bregazzi VS, LaRue SM, McNiel E, et al.: Treatment with a com- 222. Boston SE, Duerr F, Bacon N, et al.: Intraoperative radiation for
bination of doxorubicin, surgery, and radiation versus surgery and limb sparing of the distal aspect of the radius without transcarpal
radiation alone for cats with vaccine-associated sarcomas: 25 cases plating in five dogs, Vet Surg 36:314–323, 2007.
(1995-2000), J Am Vet Med Assoc 218:547–550, 2001. 223. Boston SE, Vinayak A, Lu X, et al.: Outcome and complications in
203. Cohen M, Wright JC, Brawner WR, et al.: Use of surgery and dogs with appendicular primary bone tumors treated with stereo-
electron beam irradiation, with or without chemotherapy, for treat- tactic radiotherapy and concurrent surgical stabilization, Vet Surg
ment of vaccine-associated sarcomas in cats: 78 cases (1996-2000), 46:829–837, 2017.
J Am Vet Med Assoc 219:1582–1589, 2001. 224. Fertil B, Malaise E: Intrinsic radiosensitivity of human cell lines
204. Mayer MN, Treuil PL, LaRue SM: Radiotherapy and surgery for is correlated with radioresponsiveness of human tumors: analy-
feline soft tissue sarcoma, Vet Radiol Ultrasound 50:669–672, 2009. sis of 101 published survival curves, Int J Radiol Oncol Biol Phys
205. Nolan MW, Griffin LR, Custis JT, et al.: Stereotactic body radia- 11:1699–1707, 1985.
tion therapy for treatment of injection-site sarcomas in cats: 11 225. Bump EA, Braunhut SJ, Palayoor ST, et al.: Novel concepts in
cases (2008-2012), J Am Vet Med Assoc 243:526–531, 2013. modification of radiation sensitivity, Int J Radiol Oncol Biol Phys
206. Frimberger AE, Moore AS, LaRue SM, et al.: Radiotherapy of 29:249–253, 1994.
incompletely resected, moderately differentiated mast cell tumors 226. Vose JM: Current approaches to the management of non-Hodg-
in the dog: 37 cases (1989-1993), J Am Anim Hosp Assoc 33:320– kin’s lymphoma, Semin Oncol 25:483–491, 1998.
324, 1997. 227. Yahalom J: Radiation therapy in the treatment of lymphoma, Curr
207. LaDue T, Price GS, Dodge R, et al.: Radiation therapy for incom- Opin Oncol 11:370–374, 1999.
pletely resected canine mast cell tumors, J Am Anim Hosp Assoc 228. Fidias P, Spiro I, Sobczak ML, et al.: Long-term results of com-
39:57–62, 1998. bined modality therapy in primary bone lymphomas, Int J Radiat
208. Kry KL, Boston SE: Additional local therapy with primary re-exci- Oncol Biol Phys 45:1213–1218, 1999.
sion or radiation therapy improves survival and local control after 229. Giger U, Evans SM, Hendrick MJ, et al.: Orthovoltage radiother-
incomplete or close surgical excision of mast cell tumors in dogs, apy of primary lymphoma of bone in a dog, J Am Vet Med Assoc
Vet Surg 43:182–189, 2014. 195:627–630, 1989.
209. Chaffin K, Thrall DE: Results of radiation therapy in 19 dogs with 230. Kirova YM, Piedbois Y, Haddad E, et al.: Radiotherapy in the
cutaneous mast cell tumor and regional lymph node metastasis, Vet management of mycosis fungoides: indications, results, prognosis.
Radiol Ultrasound 43:392–395, 2002. Twenty years experience, Radiother Oncol 51:147–151, 1999.
210. Lejeune A, Skorupski K, Frazier S, et al.: Aggressive local therapy 231. Kirova YM, Piedbois Y, Le Bourgeois JP: Radiotherapy in the
combined with systemic chemotherapy provides long-term control management of cutaneous B-cell lymphoma. Our experience in 25
in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012), cases, Radiother Oncol 52:15–18, 1999.
Vet Comp Oncol 13:267–280, 2015. 232. Elmslie RE, Ogilvie GK, Gillette EL, et al.: Radiotherapy with
211. LaRue SM, Withrow SJ, Powers BE, et al.: Limb-sparing treatment and without chemotherapy for localized lymphoma in 10 cats, Vet
for osteosarcoma in dogs, J Am Vet Med Assoc 195:1734–1744, Radiol 32:277–280, 1991.
1989. 233. Meleo KA: The role of radiotherapy in the treatment of lymphoma
212. Thrall DE, Dewhirst MW, Page RL, et al.: A comparison of tem- and thymoma, Vet Clin North Am Sm Anim Pract 27:115–129,
peratures in canine solid tumours during local and whole-body 1997.
hyperthermia administered alone and simultaneously, Int J Hyper- 234. Gustafson NR, Lana SE, Mayer MN, et al.: A preliminary assess-
thermia 6:305–317, 1990. ment of whole-body radiotherapy interposed within a chemother-
213. Farese JP, Milner R, Thompson MS, et al.: Stereotactic radiosur- apy protocol for canine lymphoma, Vet Comp Oncol 2:125–131,
gery for treatment of osteosarcomas involving the distal portions of 2004.
the limbs in dogs, J Am Vet Med Assoc 225:1567–1572, 2004. 235. Williams LE, Johnson JL, Hauck ML, et al.: Chemotherapy fol-
214. Dickerson ME, Page RL, LaDue TA, et al.: Retrospective analysis lowed by half-body radiation therapy for canine lymphoma, J Vet
of axial skeleton osteosarcoma in 22 large-breed dogs, J Vet Intern Intern Med 18:703–709, 2004.
Med 15:120–124, 2001. 236. Escobar C, Grindem C, Neel JA, et al.: Hematologic changes after
215. Vakaet LA, Boterberg T: Pain control by ionizing radiation of bone total body irradiation and autologous transplantation of hemato-
metastasis, Int J Dev Biol 48:599–606, 2004. poietic peripheral blood progenitor cells in dogs with lymphoma,
216. Steenland E, Leer JW, van Houwelingen H, et al.: The effect of Vet Pathol 49:341–343, 2012.
a single fraction compared to multiple fractions on painful bone 237. Warry EE, Willcox JL, Suter SE: Autologous peripheral blood
metastases: a global analysis of the dutch bone metastasis study, hematopoietic cell transplantation in dogs with T-cell lymphoma,
Radiother Oncol 52:101–109, 1999. J Vet Intern Med 28:529–537, 2014.
217. Knapp-Hoch HM, Fidel JL, Sellon RK, et al.: An expedited pal- 238. Willcox JL, Pruitt A, Suter SE: Autologous peripheral blood hema-
liative radiation protocol for lytic or proliferative lesions of appen- topoietic cell transplantation in dogs with B-cell lymphoma, J Vet
dicular bone in dogs, J Am Anim Hosp Assoc 45:24–32, 2009. Intern Med 26:1155–1163, 2012.